CNS Pharmaceuticals downgraded to hold from buy at Maxim Group

1 BUSINESS

Business News - Opportunities - Reviews

 

 

CNS Pharmaceuticals Inc.

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply